Structural studies of the TGF-βs and their receptors - Insights into evolution of the TGF-β superfamily

FEBS Letters

Volumn 586, Issue 14, 2012, Pages 1860-1870

  Hinck, Andrew P ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

Evolution; Receptor complex; Signaling protein; Specificity; Structure; TGF

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; ACTIVIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; GROWTH DIFFERENTIATION FACTOR 5; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ALPHA HELIX; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; EVOLUTIONARY ADAPTATION; HUMAN; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; RECEPTOR BINDING; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

EID: 84862752910     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.05.028     Document Type: Review

References (79)

1. V. Kaartinen, J.W. Voncken, C. Shuler, D. Warburton, D. Bu, N. Heisterkamp, and J. Groffen Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction Nat. Genet. 11 1995 415 421
2. A.B. Kulkarni Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death Proc. Nat. Acad. Sci. U S A 90 1993 770 774
3. G. Proetzel Transforming growth factor-beta 3 is required for secondary palate fusion Nat. Genet. 11 1995 409 414
4. L.P. Sanford, I. Ormsby, A.C. Gittenberger-de Groot, H. Sariola, R. Friedman, G.P. Boivin, E.L. Cardell, and T. Doetschman TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes Development 124 1997 2659 2670
5. M.M. Shull Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Nature 359 1992 693 699
6. J.J. Letterio, and A.B. Roberts Regulation of immune responses by TGF-beta Annu. Rev. Immunol. 16 1998 137 161
7. S. O'Kane, and M.W. Ferguson Transforming growth factor beta s and wound healing Int. J. Biochem. Cell Biol. 29 1997 63 78
8. D. Pohlers TGF-beta and fibrosis in different organs - molecular pathway imprints Biochim. Biophys. Acta 1792 2009 746 756
9. S.D. Markowitz, and A.B. Roberts Tumor suppressor activity of the TGF-beta pathway in human cancers Cytokine Growth Factor Rev. 7 1996 93 102
10. J. Massagué TGFbeta in Cancer Cell 134 2008 215 230
11. A.B. Roberts, and L.M. Wakefield The two faces of transforming growth factor beta in carcinogenesis Proc. Nat. Acad. Sci. U S A 100 2003 8621 8623
12. K. Miyazono, S. Maeda, and T. Imamura BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk Cytokine Growth Factor Rev. 16 2005 251 263
13. J.A. King, E.E. Storm, P.C. Marker, R.J. Dileone, and D.M. Kingsley The role of BMPs and GDFs in development of region-specific skeletal structures Ann. N. Y. Acad. Sci. 785 1996 70 79
14. T.K. Woodruff, and J.P. Mather Inhibin, activin and the female reproductive axis Annu. Rev. Physiol. 57 1995 219 244
15. C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium Exp. Biol. Med. 227 2002 724 752
16. A. Franchini, D. Malagoli, and E. Ottaviani Cytokines and invertebrates: TGF-beta and PDGF Curr. Pharm. Des. 12 2006 3025 3031
17. P.A. Jensen, X. Zheng, T. Lee, and M.B. O'Connor The Drosophila activin-like ligand Dawdle signals preferentially through one isoform of the Type-I receptor Baboon Mech. Dev. 126 2009 950 957
18. H. Yamashita, P. ten Dijke, P. Franzen, K. Miyazono, and C.H. Heldin Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta J. Biol. Chem. 269 1994 20172 20178
19. J.L. Wrana, L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X.F. Wang, and J. Massague TGF beta signals through a heteromeric protein kinase receptor complex Cell 71 1992 1003 1014
20. J. Greenwald, W.H. Fischer, W.W. Vale, and S. Choe Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase Nat. Struct. Biol. 6 1999 18 22
21. J.L. Wrana, L. Attisano, R. Wieser, F. Ventura, and J. Massague Mechanism of activation of the TGF-beta receptor Nature 370 1994 341 347
22. J. Massague, and D. Wotton Transcriptional control by the TGF-beta/Smad signaling system EMBO J. 19 2000 1745 1754
23. Y. Shi, and J. Massague Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
24. A.V. Bakin, C. Rinehart, A.K. Tomlinson, and C.L. Arteaga P38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration J. Cell Sci. 115 2002 3193 3206
25. A.V. Bakin, A.K. Tomlinson, N.A. Bhowmick, H.L. Moses, and C.L. Arteaga Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration J. Biol. Chem. 275 2000 36803 36810
26. M.T. Hartsough, and K.M. Mulder Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells J. Biol. Chem. 270 1995 7117 7124
27. B.A. Hocevar, T.L. Brown, and P.H. Howe TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway EMBO J. 18 1999 1345 1356
28. M.A. Huber NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J. Clin. Invest. 114 2004 569 581
29. M. Oft, R.J. Akhurst, and A. Balmain Metastasis is driven by sequential elevation of H-ras and Smad2 levels Nat. Cell Biol. 4 2002 487 494
30. M. Oft, K.H. Heider, and H. Beug TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis Curr. Biol. 8 1998 1243 1252
31. M. Oft, J. Peli, C. Rudaz, H. Schwarz, H. Beug, and E. Reichmann TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells Genes Dev. 10 1996 2462 2477
32. Y.G. Chen, A. Hata, R.S. Lo, D. Wotton, Y. Shi, N. Pavletich, and J. Massague Determinants of specificity in TGF-beta signal transduction Genes Dev. 12 1998 2144 2152
33. R.S. Lo, Y.G. Chen, Y. Shi, N.P. Pavletich, and J. Massague The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors EMBO J. 17 1998 996 1005
34. M. Laiho, F.M. Weis, F.T. Boyd, R.A. Ignotz, and J. Massague Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II J. Biol. Chem. 266 1991 9108 9112
35. L. Attisano, J.L. Wrana, E. Montalvo, and J. Massague Activation of signalling by the activin receptor complex Mol. Cell. Biol. 16 1996 1066 1073
36. J. Massague TGF-beta signal transduction Annu. Rev. Biochem. 67 1998 753 791
37. F. Liu, F. Ventura, J. Doody, and J. Massague Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs Mol. Cell. Biol. 15 1995 3479 3486
38. H. Nishitoh Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5 J. Biol. Chem. 271 1996 21345 21352
39. T. Nohno, T. Ishikawa, T. Saito, K. Hosokawa, S. Noji, D.H. Wolsing, and J.S. Rosenbaum Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors J. Biol. Chem. 270 1995 22522 22526
40. B.L. Rosenzweig, T. Imamura, T. Okadome, G.N. Cox, H. Yamashita, P. ten Dijke, C.H. Heldin, and K. Miyazono Cloning and characterization of a human type II receptor for bone morphogenetic proteins Proc. Nat. Acad. Sci. U S A 92 1995 7632 7636
41. B.B. Koenig Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells Mol. Cell. Biol. 14 1994 5961 5974
42. A. Penton Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor Cell 78 1994 239 250
43. H. Yamashita, P. ten Dijke, D. Huylebroeck, T.K. Sampath, M. Andries, J.C. Smith, C.H. Heldin, and K. Miyazono Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects J. Cell Biol. 130 1995 217 226
44. J. Greenwald, J. Groppe, P. Gray, E. Wiater, W. Kwiatkowski, W. Vale, and S. Choe The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly Mol. Cell 11 2003 605 617
45. T. Kirsch, W. Sebald, and M.K. Dreyer Crystal structure of the BMP-2-BRIA ectodomain complex Nat. Struct. Biol. 7 2000 492 496
46. G.P. Allendorph, W.W. Vale, and S. Choe Structure of the ternary signaling complex of a TGF-beta superfamily member Proc. Nat. Acad. Sci. U S A 103 2006 7643 7648
47. D. Weber, A. Kotzsch, J. Nickel, S. Harth, A. Seher, U. Mueller, W. Sebald, and T.D. Mueller A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor BMC Struct. Biol. 7 2007 6
48. P.J. Hart, S. Deep, A.B. Taylor, Z. Shu, C.S. Hinck, and A.P. Hinck Crystal structure of the human TbetaR2 ectodomain-TGF-beta3 complex Nat. Struct. Biol. 9 2002 203 208
49. J. Groppe Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding Mol. Cell 29 2008 157 168
50. S. Radaev, Z. Zou, T. Huang, E.M. Lafer, A.P. Hinck, and P.D. Sun Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily J. Biol. Chem. 285 2010 14806 14814
51. J.E. Zuniga Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent J. Mol. Biol. 354 2005 1052 1068
52. S. Keller, J. Nickel, J.L. Zhang, W. Sebald, and T.D. Mueller Molecular recognition of BMP-2 and BMP receptor IA Nat. Struct. Mol. Biol. 11 2004 481 488
53. J.E. Zuniga, U. Ilangovan, P. Mahlawat, C.S. Hinck, T. Huang, J.C. Groppe, D.G. McEwen, and A.P. Hinck The TbetaR-I Pre-Helix Extension Is Structurally Ordered in the Unbound Form and Its Flanking Prolines Are Essential for Binding J. Mol. Biol. 412 2011 601 618
54. S. Deep, K.P. Walker 3rd, Z. Shu, and A.P. Hinck Solution structure and backbone dynamics of the TGFbeta type II receptor extracellular domain Biochemistry 42 2003 10126 10139
55. J. Klages, A. Kotzsch, M. Coles, W. Sebald, J. Nickel, T. Muller, and H. Kessler The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding Biochemistry 47 2008 11930 11939
56. J. Nickel, A. Kotzsch, W. Sebald, and T.D. Mueller A single residue of GDF-5 defines binding specificity to BMP receptor IB J. Mol. Biol. 349 2005 933 947
57. J. Nickel, W. Sebald, J.C. Groppe, and T.D. Mueller Intricacies of BMP receptor assembly Cytokine Growth Factor Rev. 20 2009 367 377
58. J. Greenwald, M.E. Vega, G.P. Allendorph, W.H. Fischer, W. Vale, and S. Choe A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors Mol. Cell 15 2004 485 489
59. T.B. Thompson, T.K. Woodruff, and T.S. Jardetzky Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions EMBO J. 22 2003 1555 1566
60. M.J. Goumans, G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors EMBO J. 21 2002 1743 1753
61. A.C. Daly, R.A. Randall, and C.S. Hill Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth Mol. Cell. Biol. 28 2008 6889 6902
62. D. Rai, S.W. Kim, M.R. McKeller, P.L. Dahia, and R.C. Aguiar Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis Proc. Nat. Acad. Sci. U S A 107 2010 3111 3116
63. C.A. Harrison, P.C. Gray, S.C. Koerber, W. Fischer, and W. Vale Identification of a functional binding site for activin on the type I receptor ALK4 J. Biol. Chem. 278 2003 21129 21135
64. W. Sebald, and T.D. Mueller The interaction of BMP-7 and ActRII implicates a new mode of receptor assembly Trends Biochem. Sci. 28 2003 518 521
65. S. Daopin, K.A. Piez, Y. Ogawa, and D.R. Davies Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily Science 257 1992 369 373
66. M.P. Schlunegger, and M.G. Grutter An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2 Nature 358 1992 430 434
67. A.P. Hinck Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2 Biochemistry 35 1996 8517 8534
68. P.R. Mittl, J.P. Priestle, D.A. Cox, G. McMaster, N. Cerletti, and M.G. Grutter The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding Protein Sci. 5 1996 1261 1271
69. C. Scheufler, W. Sebald, and M. Hulsmeyer Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution J. Mol. Biol. 287 1999 103 115
70. G.P. Allendorph, M.J. Isaacs, Y. Kawakami, J.C. Izpisua Belmonte, and S. Choe BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors Biochemistry 46 2007 12238 12247
71. D.L. Griffith, P.C. Keck, T.K. Sampath, D.C. Rueger, and W.D. Carlson Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily Proc. Nat. Acad. Sci. U S A 93 1996 878 883
72. M.A. Brown Crystal structure of BMP-9 and functional interactions with pro-region and receptors J. Biol. Chem. 280 2005 25111 25118
73. H. Schreuder, A. Liesum, J. Pohl, M. Kruse, and M. Koyama Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites Biochem. Biophys. Res. Commun. 329 2005 1076 1086
74. C. Grütter A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions Proc. Nat. Acad. Sci. U S A 105 2008 20251 20256
75. A.E. Harrington, S.A. Morris-Triggs, B.T. Ruotolo, C.V. Robinson, S. Ohnuma, and M. Hyvonen Structural basis for the inhibition of activin signalling by follistatin EMBO J. 25 2006 1035 1045
76. T. Huang TGF-beta signalling is mediated by two autonomously functioning TbetaRI:TbetaRII pairs EMBO J. 30 2011 1263 1276
77. J. Massagué A very private TGF-beta receptor embrace Mol. Cell 29 2008 149 150
78. J.S. Papadopoulos, and R. Agarwala COBALT: constraint-based alignment tool for multiple protein sequences Bioinformatics 23 2007 1073 1079
79. T.B. Thompson, T.F. Lerch, R.W. Cook, T.K. Woodruff, and T.S. Jardetzky The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding Dev. Cell 9 2005 535 543